Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.36
16% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2002 | 2003 | 2004 | 2018 | 2019 | 2020 | 2021 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7M | $3.3M | $1.2M | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $1.4M | $1.2M | $654.0K | $1.1K | $1.1K | $779 | $0 | $0 |
| Gross profit | $2.3M | $2.1M | $527.0K | −$1.1K | −$1.1K | −$779 | $0 | $0 |
| Gross margin | 63.0% | 63.0% | 44.6% | — | — | — | — | — |
| R&D | $773.0K | $780.0K | $376.0K | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$2.0M | −$1.6M | −$1.7M | −$818.9K | −$403.9K | −$14.4M | −$62.0K | −$5.8K |
| EBITDA | −$1.1M | −$1.5M | −$1.8M | −$817.8K | −$181.4K | −$14.7M | $228.7K | −$5.8K |
| Net income | −$2.0M | −$1.5M | −$1.6M | −$850.4K | −$207.6K | −$97.5M | −$104.6M | −$5.8K |
| Net margin | -53.1% | -46.3% | -132.5% | — | — | — | — | — |
| EPS (diluted) | -1951000.00 | -1520000.00 | -782500.00 | -0.72 | -0.12 | -6.76 | -3.42 | 0.00 |
Annual figures · source: Financial Modeling Prep
ONCOLOGY PHARMA INC
No one on the platform currently holds ONPH.
No tracked institution reports a position in ONPH as of their last filing.
| Execution date | Ratio |
|---|---|
| 2020-10-09 | 1-for-100reverse |
No one on the platform has traded ONPH yet.
| $4359 |
| — |
| CALACalithera Biosciences, Inc. | $0.00 | +0.00% | $1949 | — |
| INNDInnerScope Hearing Technologies, Inc. | $0.00 | +0.00% | $459 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$RGBP $ONPH @honky_stonky LM is getting out of hand with fantasy instead of reality. Even if ONPH gets ressurected, it almost certainly won't be a drug company, yet he assumes that and that they will do "business" with RGBP. And yes, anyone that actually knows how to do due diligence would see that the shares ONPH gave $RGBP turned out to be worthess and have been written down in the financials. That's just want $RGBP needs! More worthless shares. It's hard to beleive the insanity that man posts, and he's getting worse!
View on StockTwits ↗$ONPH is currently an empty shell and reverse merger candidate. The former company and management no longer have any association with this ticker. Premashanth Kumalarasan was granted custodianship of ONPH through the Clark County Courts in Nevada.
View on StockTwits ↗$RGBP $ONPH LMCG has got to be one of the most obtuse posters on here. Does he not know what happened ONPH's last management? The company was a fraud - just like RGBP - and the guy who ran the fraud was convicted of fraud and sent to prison. https://www.justice.gov/usao-ma/pr/notice-potential-victims-securities-fraud-case-involving-stocks-onph-fpwm SO that brings up the question as to how and why David Koos, RGBP's CEO, got involved with this guy. Well, the CEO of ONPH was from Carlsbad, CA, not far from San Diego. As they say, fraudsters like to hang around with each other. IT was ONPH that saved Koos' ass with that very convenient "deal" that gave Koos ONPH shares when they were severely inflated that allowed him to pay off Chemdiv when he stiffed Chemdiv over $1 million by not paying his invoices to that company for services rendered. Koos needs to be cell mates with Padilla. They are both cut from the same fraudulent cloth.
View on StockTwits ↗$RGBP $ONPH Here is a screenshot of Oncology Pharma's recent filings and a new rating as Pink with a yield sign on OTCMarkets which is an upgrade now from being on the grey sheets Expert Market. As you can see, the CEO of that company is trying to resurrect ONPH with some new filings for an annual report and quarterly report but is still listed as a "Shell" company. What he plans to do with it is a mystery at this point. But they did have that licensing agreement with Regen. Maybe they'll go back to work on that, but who knows? 🤷♂️ You can check things out more if you'd like... Here's the link: https://www.otcmarkets.com/stock/ONPH/disclosure
View on StockTwits ↗$RGBP $ONPH I thought I'd let people know that Oncology Pharma, the company that Regen did the licensing agreement with way back in April 2021 is waking up again. See the chart... It started perking up again at the end of February and hit a high of .088 with a close in the .07s just today. The lowest it ever traded was .004 as a "Shell" company. So, how Regen is trading below a penny is beyond me and totally unjustified compared to a shell company like ONPH. 🤷♂️
View on StockTwits ↗How would a reasonable person know that @LoveMonsterCG is paid by $RGBP to post? Look at his watch list. All of the companies Koos has/had relationships like $ONPH, are on it, and hardly any others! no one else on this entire board has all these companies in his watch list! (It will be funny to see if he removes some of them).
View on StockTwits ↗$ONPH Last I was here and in touch with the OTC, ONPH had acquired, RGBP, I believe. What happened since? I’ve lost touch.
View on StockTwits ↗$ONPH looks like my decimal place was a little off .0001
View on StockTwits ↗$ONPH Phase 3 trial w/est Mar completion date NCT02194842: https://www.clinicaltrials.gov/study/NCT02194842 Trial Tracker: https://www.fdatracker.com/trial-tracker/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.